Trial · NCT03297294
Results by group79
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 79
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | EMA401 100mg BID DB | Week 4 | -1.0 | Standard Error 0.21 | scores on a scale |
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | Placebo BID DB | Week 4 | -0.8 | Standard Error 0.18 | scores on a scale |
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | EMA401 100mg BID DB | Week 8 | -1.7 | Standard Error 0.29 | scores on a scale |
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | Placebo BID DB | Week 8 | -1.1 | Standard Error 0.26 | scores on a scale |
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | EMA401 100mg BID DB | Week 12 | -1.9 | Standard Error 0.31 | scores on a scale |
| Change in Weekly Mean 24-hour Average Pain Score Using the 11 Point Numerical Rating Scale (NRS) From Baseline to Week 12 | Placebo BID DB | Week 12 | -1.3 | Standard Error 0.27 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | EMA401 100mg BID DB | Week 4 | -1.2 | Standard Error 0.19 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | Placebo BID DB | Week 4 | -1.0 | Standard Error 0.18 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | EMA401 100mg BID DB | Week 8 | -1.3 | Standard Error 0.25 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | Placebo BID DB | Week 8 | -0.9 | Standard Error 0.22 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | EMA401 100mg BID DB | Week 12 | -1.6 | Standard Error 0.32 | scores on a scale |
| Change in Neuropathic Pain Symptom Inventory (NPSI) From Baseline to Week 12 | Placebo BID DB | Week 12 | -1.1 | Standard Error 0.26 | scores on a scale |
| Change in Brief Pain Inventory-Short Form Interference (BPI-SF) Mean Total Score From Baseline to Week 12 | EMA401 100mg BID DB | -12.03 | Standard Deviation 13.336 | scores on a scale | |
| Change in Brief Pain Inventory-Short Form Interference (BPI-SF) Mean Total Score From Baseline to Week 12 | Placebo BID DB | -10.83 | Standard Deviation 14.602 | scores on a scale | |
| Change in Weekly Mean of the 24-hour Worst Pain Score, Using an 11-point NRS, From Baseline to Week 12 | EMA401 100mg BID DB | -1.63 | Standard Deviation 1.837 | scores on numeric rating scale | |
| Change in Weekly Mean of the 24-hour Worst Pain Score, Using an 11-point NRS, From Baseline to Week 12 | Placebo BID DB | -1.28 | Standard Deviation 1.577 | scores on numeric rating scale | |
| Number of Participants Per Patient Global Impression of Change Category at Week 12 | EMA401 100mg BID DB | Very much improved | 4 | Participants | |
| Number of Participants Per Patient Global Impression of Change Category at Week 12 | Placebo BID DB | Very much improved | 2 | Participants | |
| Number of Participants Per Patient Global Impression of Change Category at Week 12 | EMA401 100mg BID DB | Much improved | 7 | Participants | |
| Number of Participants Per Patient Global Impression of Change Category at Week 12 | Placebo BID DB | Much improved | 11 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03297294/results